✦ LIBER ✦

Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review

✍ Scribed by Schillie, Sarah F.; Murphy, Trudy V.

Book ID: 118249951
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 325 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.12.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Persistence of immunity and seroprotecti

Persistence of immunity and seroprotection 4 years after a primary vaccination schedule with a Hansenula polymorpha recombinant hepatitis B vaccine

✍ A Lepetic; C Biscayart; M Seigelchifer; R Arduino; D Stamboulian 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 91 KB

High seroprotection rate induced by low

High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates

✍ F Shokri; A Jafarzadeh 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Morphea profunda in a young infant after

Morphea profunda in a young infant after hepatitis B vaccination

✍ Rym Benmously Mlika; Nesrine Kenani; Talel Badri; Houda Hammami; Jihene Hichri; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 560 KB

High Seroprotection Rate Induced by Intr

High Seroprotection Rate Induced by Intradermal Administration of a Recombinant Hepatitis B Vaccine in Young Healthy Adults: Comparison with Standard Intramuscular Vaccination

✍ Mohammad J. Ghabouli; Amir Hossein Sabouri; Naser Shoeibi; Sepideh Naghibzadeh B 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 83 KB

Field evaluation of the efficacy and imm

Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants

✍ Alexander Milne; David J. West; Dang Van Chinh; Chris D. Moyes; Gabriele Poersch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract A study involving more than 2,000 infants was conducted in Vietnam to assess the field effectiveness and immunogenicity of recombinant hepatitis B vaccine given at birth, 1 month, 2 months, without concomitant hepatitis B immune globulin (HBIG). All received a 5 μg dose of H‐B‐VAX™II at

Safety and Immunogenicity of a Yeast-Der

Safety and Immunogenicity of a Yeast-Derived Recombinant Hepatitis B Vaccine in Bulgarian Newborns

✍ M. Kojouharova; P. Teoharov; T. Bahtchevanova; I. Maeva; A. Eginlian; M. Deneva 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 81 KB